- Report
- January 2026
- 364 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 279 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 177 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 279 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 485 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 182 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 284 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 467 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 273 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 276 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 371 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 273 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 272 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 268 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 279 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 475 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 476 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more